Lovastatin 60 mg (DrugBank: Lovastatin)
11 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
6 | パーキンソン病 | 0 |
34 | 神経線維腫症 | 1 |
46 | 悪性関節リウマチ | 0 |
79 | 家族性高コレステロール血症(ホモ接合体) | 0 |
156 | レット症候群 | 0 |
160 | 先天性魚鱗癬 | 0 |
195 | ヌーナン症候群 | 0 |
206 | 脆弱X症候群 | 0 |
263 | 脳腱黄色腫症 | 0 |
280 | 巨大動静脈奇形(頚部顔面又は四肢病変) | 0 |
310 | 先天異常症候群 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03826940 (ClinicalTrials.gov) | February 19, 2019 | 23/1/2019 | From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1 | Linking Inhibition From Molecular to Systems and Cognitive Levels: a Preclinical and Clinical Approach in Autism Spectrum Disorders and Neurofibromatosis. | Autism Spectrum Disorder;Neurofibromatosis 1 | Drug: Lovastatin 60 MG;Drug: Placebos | University of Coimbra | NULL | Recruiting | 16 Years | 65 Years | All | 30 | N/A | Portugal |